GlassScriptPhysician profile
Lawrence A Coskey
NPI 1942276738
$5,666.21
in general payments reported to CMS, 2019-2025
39 companies · $1,065 in 2025
The $1,065 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,304 · 2020: $497 · 2021: $265 · 2022: $457 · 2023: $1,090 · 2024: $989 · 2025: $1,065.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,065 · Education: $78.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,064.70 |
| Education | $78.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,015.46 | 2019-2025 | Ofev, Jascayd, Spiriva Respimat |
| Glaxosmithkline, LLC. | $1,005.05 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Astrazeneca Pharmaceuticals LP | $816.22 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Insmed, INC. | $515.73 | 2019-2025 | Arikayce |
| Merck Sharp & Dohme LLC | $175.72 | 2019-2025 | Recarbrio, Zerbaxa, Keytruda |
| Electromed, INC. | $162.92 | 2019-2025 | Smartvest |
| Inari Medical, INC. | $145.01 | 2020-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Mylan Specialty L.P. | $137.33 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $129.14 | 2023-2024 | Opsumit, Uptravi |
| Amgen INC. | $128.41 | 2024-2025 | Tezspire |
| Genentech USA, INC. | $122.35 | 2019-2020 | |
| Genzyme Corporation | $108.29 | 2020-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $107.69 | 2022-2025 | Cuvitru, Hyqvia |
| Janssen Pharmaceuticals, INC | $94.93 | 2022-2023 | Xarelto |
| United Therapeutics Corporation | $87.82 | 2023-2025 | Tyvaso, Tyvaso |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $78.99 | 2025 | |
| Baxter Healthcare | $72.37 | 2023-2025 | Hillrom - Vest System Model 105 Home Care |
| Pfizer INC. | $66.73 | 2023-2024 | |
| Sunovion Pharmaceuticals INC. | $59.66 | 2019-2020 | |
| Pulmonx Corporation | $59.29 | 2020-2023 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Hospira, INC. | $52.61 | 2025 | |
| Grifols USA, LLC | $52.40 | 2019-2024 | Prolastin-C Liquid |
| Novartis Pharmaceuticals Corporation | $50.06 | 2019-2024 | |
| Intuitive Surgical, INC. | $49.04 | 2021 | |
| Jazz Pharmaceuticals INC. | $42.36 | 2019 | |
| Gilead Sciences, INC. | $37.26 | 2019 | |
| Stryker Corporation | $34.61 | 2025 | Flowtriever |
| Verona Pharma, INC. | $30.29 | 2025 | Ohtuvayre |
| Lilly USA, LLC | $25.80 | 2025 | Zepbound |
| Regeneron Healthcare Solutions, INC. | $23.87 | 2024 | Dupixent |
| Astellas Pharma US INC | $23.81 | 2019 | |
| Viatris Specialty LLC | $23.35 | 2025 | Yupelri |
| Teva Pharmaceuticals USA, INC. | $22.24 | 2019 | |
| Resmed Corp | $21.76 | 2019 | |
| Fisher & Paykel Healthcare INC | $21.75 | 2023 | Fisher & Paykel Healthcare |
| Portola Pharmaceuticals, LLC | $21.56 | 2019 | |
| Philips North America LLC | $16.55 | 2025 | Vest Therapy Und |
| Sanofi Pasteur INC. | $15.84 | 2019 | |
| Circassia INC. | $11.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Coskey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.